סטרפטז 1500000

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

STREPTOKINASE

Disponible depuis:

GENMEDIX , ISRAEL

Code ATC:

B01AD01

forme pharmaceutique:

אבקה להכנת תמיסה לזריקה

Composition:

STREPTOKINASE 1500000 IU

Mode d'administration:

תוך-עורקי, תוך-ורידי

Type d'ordonnance:

מרשם נדרש

Fabriqué par:

CSL BEHRING GmbH, GERMANY

Groupe thérapeutique:

STREPTOKINASE

Domaine thérapeutique:

STREPTOKINASE

indications thérapeutiques:

Systemic administration: in deep vein thromboses, lung embolism, acute myocardial infarction for re-opening of coronary vessels. In acute and subacute thromboses of peripheral arteries and chronic occlusive arterial diseases, occlusion of central retinal artery or vein. Local administration: in acute myocardial infarction for re-opening of coronary vessels, in acute, subacute and chronic thromboses as well as embolisms of peripheral arteries.

Date de l'autorisation:

2012-11-30